Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development

Oxaliplatin (OHP)-induced peripheral neurotoxicity (OIPN) is a severe clinical problem and potentially permanent side effect of cancer treatment. For the management of OIPN, accurate diagnosis and understanding of significant risk factors including genetic vulnerability are essential to improve know...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Zhao, Bing, Gao, Xuejiao, Sun, Jinbing, Ye, Juan, Li, Jun, Cao, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532307/
https://www.ncbi.nlm.nih.gov/pubmed/34686205
http://dx.doi.org/10.1186/s13046-021-02141-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532307/
https://www.ncbi.nlm.nih.gov/pubmed/34686205
http://dx.doi.org/10.1186/s13046-021-02141-z

Ejemplares similares